NEW YORK, June 20, 2022 /PRNewswire/ — The “Styrene Butadiene (SB) Latex Market by Application (Paper processing, Fiber and carpet processing, Glass fiber adhesives, Adhesives, and Others) and Geography (APAC, Europe, North America, Middle East, and Africa, and South America) – Forecast…
Related Posts
iBASEt Reports Record Revenue, Profitability and Backlog for Fiscal 2022, Driven by Surge in New and Expanded Licensing
Record license revenue increase of 57% year-over-year Innovations on display at Farnborough International Airshow (Stand 4315, Hall 4) LAKE FOREST,…
CBAK Energy to Co-Develop Na-ion Cells with Chinese Battery Manufacturer
DALIAN, China, July 26, 2022 /PRNewswire/ — CBAK Energy Technology, Inc. (NASDAQ: CBAT) (“CBAK Energy,” or the “Company”), a leading…
Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.
Pharma Desk, India: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ivabradine Tablets, 5 mg and 7.5 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Corlanor Tablets, 5…
Read More “Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.” »
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.